Quest Diagnostics DGX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.9B+9.2% | $2.81B+7.1% | $2.82B+13.2% | $2.76B+15.2% | $2.65B+12.1% | ||
| $1.95B+9.2% | $1.9B+7.5% | $1.87B+11.3% | $1.82B+14.1% | $1.79B+12.2% | ||
| $942M+9.2% | $910M+6.1% | $949M+17.0% | $943M+17.3% | $863M+11.9% | ||
| 32.5%0.0pp | 32.4%-0.3pp | 33.7%+1.1pp | 34.2%+0.6pp | 32.5%0.0pp | ||
| $504M+5.9% | $504M+8.2% | $501M+11.8% | $486M+16.8% | $476M+8.2% | ||
| $37M-5.1% | $37M0.0% | $39M+21.9% | $39M+34.5% | $39M+34.5% | ||
| -$2M0.0% | $17M— | -$23M-2,200% | $20M+600% | -$2M0.0% | ||
| $2.5B+8.2% | $2.42B+7.1% | $2.43B+12.6% | $2.32B+13.8% | $2.31B+11.6% | ||
| $399M+15.3% | $386M+6.9% | $386M+17.0% | $438M+23.4% | $346M+15.3% | ||
| 13.8%+0.7pp | 13.8%0.0pp | 13.7%+0.4pp | 15.9%+1.1pp | 13%+0.4pp | ||
| -$63M+6.0% | -$64M+1.5% | -$66M-34.7% | -$67M-52.3% | -$67M-55.8% | ||
| -$65M+7.1% | -$56M+9.7% | -$58M-70.6% | -$54M-31.7% | -$70M-106% | ||
| $4M-77.8% | $7M+40.0% | $8M+33.3% | $9M— | $18M+125% | ||
| $334M+21.0% | $330M+10.4% | $328M+10.8% | $384M+22.3% | $276M+3.8% | ||
| $74M+25.4% | $81M+19.1% | $77M+18.5% | $97M+31.1% | $59M-10.6% | ||
| $252M+14.5% | $245M+10.4% | $245M+8.4% | $282M+23.1% | $220M+13.4% | ||
| 8.7%+0.4pp | 8.7%+0.3pp | 8.7%-0.4pp | 10.2%+0.7pp | 8.3%+0.1pp | ||
| $2.24+15.5% | $2.18+11.8% | $2.16+8.5% | $2.47+21.7% | $1.94+12.8% | ||
| $2.27+15.2% | $2.21+11.6% | $2.18+8.5% | $2.51+22.4% | $1.97+13.2% | ||
| 112M-0.9% | —— | 113M0.0% | 113M+0.9% | 113M+0.9% | ||
| 110M-0.9% | —— | 112M0.0% | 112M+0.9% | 111M0.0% | ||
| -$63M+6.0% | -$64M+1.5% | -$66M-34.7% | -$67M-52.3% | -$67M-55.8% | ||
| $37M-5.1% | $37M0.0% | $39M+21.9% | $39M+34.5% | $39M+34.5% | ||
| -$2M+33.3% | $8M+167% | $8M-46.7% | $13M+333% | -$3M-133% | ||
| -$2M0.0% | $17M— | -$23M-2,200% | $20M+600% | -$2M0.0% | ||
| $2.9B+9.2% | $2.81B+7.1% | $2.82B+13.2% | $2.76B+15.2% | $2.65B+12.1% | ||
| $546M+12.3% | $531M+7.1% | $528M+16.0% | $581M+23.1% | $486M+16.8% | ||
| 18.9%+0.5pp | 18.9%0.0pp | 18.8%+0.5pp | 21%+1.4pp | 18.3%+0.7pp | ||
| $399M+15.3% | $386M+6.9% | $386M+17.0% | $438M+23.4% | $346M+15.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Quest Diagnostics's revenue?
- Quest Diagnostics (DGX) generated $11.3B in revenue over the trailing twelve months, up 11.0% year over year.
- Is Quest Diagnostics profitable?
- Quest Diagnostics reported $1.0B in net income over the trailing twelve months, a 9.1% net margin.
- What are Quest Diagnostics's profit margins?
- Gross margin is 33.2% and operating margin is 14.3%, with a 9.1% net margin.
- What is Quest Diagnostics's earnings per share?
- Quest Diagnostics's diluted EPS over the trailing twelve months is $9.05.
- Where does Quest Diagnostics's income statement data come from?
- Every line is extracted from Quest Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
